One reason hospital prices may rise is that the cost of supplies and equipment that they use can go up rapidly. The Modern Healthcare/ECRI Institute Technology Price Index finds for example that the average cost of surgical tables, a mundane item, is up about 16% in the last year.
https://www.ecri.org/Pages/PriceIndex.aspxA study in the American Journal of Managed Care finds that electronic prescribing grew from 30% in 2007 to 56% in 2010, with primary care doctors being more likely to engage in it than specialists and urban doctors more frequent users than rural ones.
http://www.ajmc.com/publications/ajpb/2013/ajpb_novdec2013/Electronic-Prescription-Use-by-Specialty?utm_source=Informz&utm_medium=AJMC&utm_campaign=AJPB+Web+12%2D13%2D13A Kaiser Family Foundation brief finds that Medicare patients continue to have generally good access to physicians.
Read More
Use of hospitalists appears to be associated with lower hospital readmissions, according to a study in the Journal of Hospital Medicine.
http://www.beckershospitalreview.com/quality/study-hospitalist-presence-associated-with-reduced-readmissions.html?utm_source=H2RMinutes+PCMH+Dec.+10%2C+2013&utm_campaign=PCMH-AC+Minutes+12%2F10%2F13+&utm_medium=emailStartup Doctor on Demand has raised $3 million to grow its telehealth product to deal with non-emergency health issues, adding one more company to a crowded field.
http://medcitynews.com/2013/12/telehealth-startup-doctors-demand-raises-3m-seed-funding/?utm_source=MedCity+News+Subscribers&utm_campaign=f14c3fc367-RSS_Daily+Top+Stories&utm_medium=email&utm_term=0_c05cce483a-f14c3fc367-67648197According to a survey from Duke University and CFO Magazine, 20% of companies say they are likely to hire fewer workers, 10% may lay off employees and 40% will shift to more part-time personnel due to the reform law.
http://medcitynews.com/2013/12/obamacare-news-healthcare-reform-curbs-full-time-hiring/?utm_source=MedCity+News+Subscribers&utm_campaign=f14c3fc367-RSS_Daily+Top+Stories&utm_medium=email&utm_term=0_c05cce483a-f14c3fc367-67648197A PriceWaterhouseCooper Report finds that funding for life sciences companies seems to be lagging that for other industries, with potential positive and negative implications.
Read More
